Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02852681Phase 1Completed
Phase 1, randomised, open-label trial of estetrol in contraception (2 arms), sponsored by Estetra SRL. Primary endpoints: Maximum concentration of estetrol in plasma, Maximum concentration of drospirenone in plasma and 4 more. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02852681.